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Copyright © 2007 AHC Neuroendocrine (NE) differentiation is infrequent in testicular tumors and its histogenesis is
not well understood. The present study is aimed at elucidating the pathway of neuroendo-
crine differentiation in germ cell tumors (GCTs) of the testis. In the analysis of 46 germ cell
tumor components from 23 testicular tumors, we focused on GCTs with neuroendocrine
differentiation, 7 teratoma, 1 embryonal carcinoma and 1 neuroendocrine carcinoma by immu-
nohistochemical study and confocal laser scanning microscopy (CLSM) analysis. NE marker
positive cells were noted in the tumor with collision of teratoma and embryonal carcinoma
(E&T tumor), in the immature columnar cells of transitional form of embryonal carcinoma to
teratoma (E-T cells) and neuroendocrine carcinoma cells, in addition to the well known
mature intestinal mucosa in teratoma. Double staining for a NE marker (CGA) and a germ
cell marker (PLAP) demonstrated the localization of both proteins in the same E-T cells
confirmed by CLSM. Another finding, indicating the intimate relation between embryonal
carcinoma and neuroendcrine differentiation, is that neuroendocrine carcinoma expressed a
marker of embryonal carcinoma, CD30. The present results indicated that the NE cells might
be differentiated from embryonal carcinoma, a view that has not been proposed before, but
that is made in the present study using CLSM.
Key words: confocal laser scanning microscopy (CLSM), embryonal carcinoma, germ cell tumor,
neuroendocrine cell, testis
I. Introduction
It is well known that neuroendocrine tumors (NETs)
which produce peptide hormones are equipped with secreto-
ry granules (SGs). NETs are derived from endocrine organs
such as the anterior lobe of the pituitary, adrenal medulla
and pancreatic islets of Langerhans, or scattered endocrine
(dispersed neuroendocrine: DNE) cells such as the NE cells
originating in the respiratory, gastrointestinal and urinary
tracts, as well as the skin [23]. NETs can also be derived
from non-endocrine organs such as kidney and liver.
NETs can occur in the gonads, such as carcinoid tumors
of the testis or ovary, but are extremely rare [16]. Even when
occurring in the gonads, they often coexist with mature form
of germ cell tumor, i.e. teratoma [1, 15, 26]. In the testicular
germ cell tumors, in contrast to the ovarian ones, the terato-
matous components are often mixed with other types of germ
cell tumors [25]. Although there have been a few reports
regarding the histogenesis of neuroendocrine tumors in the
gonads [20], the detailed mechanisms of differentiation of
NETs have yet to be fully elucidated.
Because of their multipotentiality for histological dif-
ferentiation, germ cell tumors possess a variety of possible
histogenetic patterns and are classified into several types
based on their histopathological findings. Immunohisto-
chemical examination is another helpful tool to visualize theKumaki et al. 144
specific molecules in each cell. Placental alkaline phos-
phatase (PLAP), for example, is a good marker for embryo-
nal carcinoma, and CD30, another recently proposed marker
for embryonal carcinoma, is already well known as a marker
for Ki-1 lymphoma [14]. There is also a panel of markers for
neuroendocrine differentiated cells. The present study is
aimed at elucidating the possible origins of NE cells in tes-
ticular germ cell tumors using immunohistochemistry com-
bined with confocal laser scanning microscopy (CLSM).
II. Materials and Methods
Cases and histopathology
We investigated 23 testicular tumors including series of
the 20 tumors submitted as described in the previous studies
[10, 11]. All tumors were surgically excised at Tokai Uni-
versity Hospital from patients whose ages ranged between
11 months and 53 years (median age, 28.4 years). Nine
tumors were obtained from the right testis and 13 from the
left (in one case, the testis of origin was unknown). Histo-
logical diagnosis was performed according to the General
Rules for Clinical and Pathological Studies on Testicular
Tumors [22] and WHO classification [2].
Sixteen of the 23 testicular tumors contained more
than two histological components, for a total of 46 histo-
pathological components, i.e. 19 embryonal carcinomas, 8
seminomas, 8 yolk sac tumors, 10 teratomas were studied
by the following immunohistochemical methods. One neuro-
endocrine carcinoma was also examined (Table 1).
Immunohistochemistry
Resected materials were fixed in 10% formalin and
embedded in paraffin. Immunohistochemical examination
was  performed  by the polymer enhancing method (En-
vision, DAKO). In brief, after deparaffinization, endogenous
peroxidase was blocked in 0.3% H2O2-methanol solution.
Methods of antigen retrieval and the sources of antibodies
are summarized in Table 2. The NE markers studied in-
cluded chromogranin A (CGA), synaptophysin (SYN),
neuron specific enolase (NSE), and neural cell adhesion
molecule (NCAM, CD56). Placental alkaline phosphatase
(PLAP) was used as a marker for embryonal carcinoma and
seminoma. After the reaction with peroxidase-labeled poly-
mer (Envision, Dako), and the immunoreactions were visual-
ized with DAB (diaminobenzidine). In some cases, CD30
was also examined by automatic system (Ventana XT
System Discovery) as a marker of embryonal carcinoma.
Double staining by bright field visualization
We performed double staining for CGA and PLAP in
serial sections from 3 cases, in which CGA or SYN was lo-
calized, and from one case of NE carcinomas. Double stain-
ing is a useful technique for detecting multiple tissue anti-
gens in the same cells if the control studies are properly
performed [12]. DAB was used for visualization of the first
immunohistochemical staining for CGA. For immunostain-
ing for PLAP, a second antigen, the immunoreactions were
visualized using Fast Blue BB. In the process of double
staining for CGA and PLAP, both antibodies were generated
in mice, and the primary and secondary antibodies for the
first staining were removed by washing in glycine HCl buff-
er for 1–2 hr with stirring, before the immunoreaction of the
second staining.
CLSM analysis
In order to elucidate whether PLAP and CGA were
localized in the same cell, CLSM (LSM-510 META; Carl
Zeiss, Jena, Germany) in reflection and fluorescence mode
was employed on the selected immunoreacted cells on the
paraffin sections. The CLSM system included a 543-nm
helium-neon laser (for fast blue fluorescence and reflection
of DAB). Optical fluorescence signals of alkaline phospha-
tase labeled with fast blue were observed using a dichroic
beam splitter (NT 80/20/543; Carl Zeiss) and emission filter
(LP570; Carl Zeiss) [5]. Optical reflectance signals from
CGA-positive cells labeled with DAB were observed using
a dichroic beam splitter (NT 80/20/543; Carl Zeiss) without
an emission filter. Double- or triple-labeled data sets
Table 1. Histopathology of the germ cell tumors
Embryonal carcinoma 19
Teratoma 10
Seminoma 8
Yolk sac tumor 8
Neuroendocrine carcinoma 1
Table 2. Antibodies used in this study
NSE, neuron specific enolase; NCAM, Neural cell adhesion molecule; PLAP, Placental alkaline phosphatase.
Antigen retrieval *1: 0.1% Trypsin solution (0.05 M Tris-HCl buffer), 37°C, 30 min, *2: Autoclave in pH 6.0 citrate buffer solution, 121°C, 2
atm, 15 min.
Antibody dilution Clone Retrieval Company
Chromogranin A 1 : 1 (prediluted) LK2H10 — IMMUNO TECH
Synaptophysin 1 : 50 Polyclonal +*1 DAKO
NSE 1 : 100 BBS/NC/VI-H14 — DAKO
NCAM 1 : 30 1B6 +*2 NOVO CASTRA
PLAP 1 : 100 8A9 — DAKO
CD 30 1 : 30 Ber-H2 +*2 DAKONeuroendocrine Characteristic in Testicular GCTs 145
(including transmittance images) of images obtained by
CFLSM were digitized and subjected to image analysis
using LSM software version 3.2 SP2 (Carl Zeiss). Optical
imaging for 2D reconstruction of PLAP- and CGA-secret-
ing endocrine cells was performed with a C-apochromat
(×63, water immersion, NA 1.25; Carl Zeiss) objective lens.
The image resolution was 512×512 pixels (12 bits, 4096
gray levels).
Immunoelectron microscopy for CGA positive cells in 
neuroendocrine carcinoma
Immunoelectron microscopic examination was per-
formed by the pre-embedding method using paraffin sec-
tions. After immunohistochemical reaction was completed,
the reacted paraffin sections were re-fixed with 0.5–1%
glutaraldehyde. Visualization with DAB was performed,
followed by osmification and dehydration with ethanol,
after which sections were then embedded in epoxy resin.
The resin was polymerized at 60°C for 2 days. Ultrathin
sections were observed under the electron microscope
(JEOL 1200EX, JEOL Ltd., Tokyo, Japan).
III. Results
Characteristics of germ cell tumor expressing NE markers
Germ cell tumors (GCTs) often show more than two
histological elements; therefore, immunohistochemical
staining was performed for each histological component.
The results of single immunohistochemical staining are
summarized in Table 3. Expression of NE markers was iden-
tified in most of teratomas which included intestinal or res-
piratory tract. Teratomatous components usually contained
mature components of skin with or without adnexa, bron-
chus, gastrointestinal tract, bone, cartilage, muscle and neu-
ral tissue. Columnar cells in mature intestinal tissue con-
tained basally situated nucleus and cilia, and goblet cells
were also seen (Fig. 1A). A few cells in a case of embryonal
carcinoma and a case of yolk sac tumor were also positive
for CGA. Many tumor cells of the neuroendocrine carcino-
ma (NEC) were labeled for NE markers including CGA,
SYN, NSE and NCAM.
To analyze the relation between NE character and germ
cell tumors more precisely, we focused on the following
three resected tumorous elements.
(1) The first element was the collision of teratoma and
embryonal carcinoma (Fig. 1B). The columnar cells in glan-
dular structures were observed as admixed with or adjacent
to embryonal carcinomas. We called this element “E&T
tumor” (mixture of embryonal carcinoma and teratoma).
(2) For the second element, immature intestinal tubules
consisted of columnar cells with less basally oriented nuclei
and cilia, and very slight mucus production was observed
(Fig. 1C). From these features, these columnar cells were in-
terpreted as less mature intestinal cells. On the other hand,
embryonal carcinoma cells sometimes are columnar shaped
and contain clear cytoplasm [6]. They are also arranged in
papillary structure. Therefore, we designated these tumor
cells as transitional “embryo-teratoma cells” (E-T cells).
(3) The third element with striking features was
neuroendocrine carcinoma (NEC), which was composed of
small markedly atypical cells arranged in solid nests with
occasional rosette formation (Fig. 2A). Although no typical
features of carcinoid tumors, such as ribbon-like, rosette-like
or gyrus-like appearance were observed, immunohistochem-
ical staining showed positive NE markers such as CGA,
SYN, NSE and NCAM. Seminoma cells were intimately
admixture with NEC cells.
Immunohistochemical staining for germ cell tumors and 
double staining for PLAP/CD30 and CGA
Recently CD30 has been proposed as a marker of em-
bryonal carcinoma in addition to PLAP. Seminoma is also
positive for PLAP, which can be differentiated from embry-
onal carcinoma by negativity for CD30. Therefore, immuno-
histochemical stain for CD30 and double stain for germ cell
marker/NE markers were performed in the above three
tumorous elements.
Our observations clearly indicated that CLSM showed
unique fluorescence for DAB and Fast Blue BB. The former
was noticed in yellow and the latter in blue. This was partic-
ularly more discernible when two molecules were detected
in the same cell. Thus, the double-stained slides were first
examined with bright field condition and subsequently by
CLSM. The morphology and the localization in the same
cell were evaluated with improved quality by this method.
(1) For the “E&T tumor” element, PLAP and CD30-
positive cells were noted in the embryonal carcinoma and
CGA-positive NE cells were present in the intestinal
teratoma. They were not overlapping, but were next to
each other (Fig. 1E). This was also clearly discernible by
Table 3. Results of immunohistochemical staining in testicular germ cell tumors (percentage)
NE carcinoma, neuroendocrine carcinoma; CGA, chromogranin A; SYN, synaptophysin; NSE, neuron specific enolase; PLAP, Placental alka-
line phosphatase; NCAM, neural cell adhesion molecule.
Histopathology CGA SYN NSE NCAM PLAP
NE carcinoma 1/1 (100) 1/1 (100) 1/1 (100) 1/1 (100) 0/1
Teratoma 7/10 (70) 3/10 (30) 0/10 4/10 (40) 0/7
Embryonal carcinoma 1/19 (5) 0/19 6/19 (32) 0/11 16/16 (100)
Seminoma 0/8 0/8 0/8 0/5 6/6 (100)
Yolk sac tumor 1/8 (13) 0/8 0/8 2/7 (29) 4/8 (50)Kumaki et al. 146
Fig. 1. Neuroendocrine cells in germ cell tumors. Among columnar cells in mature intestinal mucosa of teratoma (A), there are neuroendocrine
cells labeled by CGA (D, G). In the area consisting of intestinal columnar cells of teratoma (black arrowhead) and embryonal carcinoma cells
(B), CGA positive neuroendocrine cells and PLAP positive embryonal carcinoma cells are closely localized but not localized in the same cells
(E, H). Immature columnar epithelial cells (C) demonstrate a few immature columnar cells are positive for both CGA and PLAP (F, I).
Bars=100 µm (A–E), 50 µm (F), 5 µm (G–I). A–C: H&E stain, D–F: double immunohistochemical stain for CGA (brown) and PLAP (blue),
and G–I: merged images of CLMS for CGA (yellow) and PLAP (cyanogen).Neuroendocrine Characteristic in Testicular GCTs 147
CSLM (Fig. 1H).
(2) For the “E-T cell” element, membranous expression
of PLAP was detected in many E-T cells and expression of
CGA was frequently observed in E-T cells. However, these
E-T cells were not labeled by CD30. Bright field double
staining for PLAP (blue) and CGA (brown) demonstrated
the localization of both proteins in the same “E-T cells”
(Figs. 1F, 3A). CLSM showed more clearly the co-localiza-
tion of PLAP on the cell membrane and CGA in the cyto-
plasm (Figs. 1I and 3D). In this case, the “E-T cells”
revealed tubular structures lined by clear and irregular
columnar cells which were histopathologically interpreted
as a transitional form exhibiting the features of both intesti-
nal cells (teratomatous) and embryonal carcinoma, with
PLAP and CGA being localized in the same cells (Fig. 3).
(3) The third group of tumor also showed the separate
groups of tumor cells, i.e. seminoma and NEC. Expression
of PLAP and CD30 was noted in seminoma, but NE markers
were negative. NEC cells were positive not only for NE
markers but also for CD30 (Fig. 4A). Even though SYN pos-
itive tumor cells were focally observed in NEC (Fig. 4C),
CGA positive NEC cells were very small in number
(Fig. 4B). Many NEC cells were positive for CD30 and
cytoplasmic localization of CD30 was clearly detected by
CLSM (Fig. 4D). CD30 expression was usually noted at the
cell membrane, as is demonstrated in embryonal carcinoma
cells (Fig. 4E). CLSM examination obviously revealed dif-
ferentiation of signal localization of CD30 in each tumor. No
tumor cells with expressions of both CD30 and NE markers
were observed.
Immunoelectron microscopy
Immunoelectron microscopy pre-embedding method
using formalin-fixed, paraffin-embedded materials after
immunoreaction with DAB colorization revealed the local-
ization of CGA in granular structures of up to 300 nm in
diameter, which were interpreted as secretory granules (SG)
(Fig. 2B). Granular structures by CLSM for CGA positive
cells in NEC cells showed similar granular structures sug-
gesting its localization in SG (Fig. 2C).
IV. Discussion
From our studies, it was clearly demonstrated that the
neuroendocrine (NE) cells appear in various types of germ
cell tumors (GCTs) of the testis including teratomas (espe-
cially in the intestinal epithelial cells), embryonal carcino-
mas and yolk sac tumors. In addition, neuroendocrine carci-
noma (NEC) was concomitantly present with seminoma in
the same tumor but separately. Histogenesis of NE cells has
been postulated to take place along various pathways, (1)
epithelial origin, (2) neural origin and (3) dedifferentiated
tumor cells. To determine how NE differentiation appears
in the testicular GCTs, we conducted an immunohistochem-
ical examination which showed that there were three dif-
ferent situations: (1) CGA-positive cells appear in mature
teratomatous intestinal glands mixed in embryonal carci-
Fig. 2. Histological, immunohistochemical and immunoelectron
microscopic features of neuroendocrine carcinoma (NEC). Tumor
consists of sheets of small and atypical epithelial cells which are
adjacent to seminoma cells (A). Immunoelectron microscopical
analysis shows that NEC cells have granules positively labeled by
CGA (B). The sizes of granules measured by electronmicroscopy
and by CLSM are approximately equal to 200–300 nm. Bars=100
µm (A), 1.0 µm (B), 0.5 µm (B, inset), 2.0 µm (C), 0.2 µm (C,
inset). A: H&E stain, B: immunohistochemical and immunoelec-
tron microscopy, C: CLSM for CGA (yellow).Kumaki et al. 148
noma “E&T tumor”, (2) CGA appears in tubular structures
(E-T cells) which exhibit the features in transition from
embryonal carcinoma to teratomatous intestinal glands, (3)
NEC separates from seminoma. By CLSM on immunohisto-
chemical double staining, the three categories noted above
were clearly observed. In particular, this novel method
specifically indicated the localization of CGA and PLAP
in the same E-T cells. These findings support the hypothesis
that the NE cells may be differentiated from embryonal
carcinoma during the process of columnar (intestinal) mor-
phogenesis (Fig. 5).
It is well known that CGA is a major component in the
secretory granules and has been used as a major NE marker
in NE cells and neuroendocrine tumors (NETs). Recently, it
has been reported that CGA gene transfection induced the
formation of secretory granules which are the morphological
feature of NE cells [4]. The molecular mechanisms for the
appearance of CGA in the embryonal carcinoma remain to
be further investigated.
Primary NET by WHO classification included (1) well
differentiated endocrine tumor (WDET) “carcinoid”, (2)
well differentiated endocrine carcinoma (WDEC) and (3)
poorly differentiated endocrine carcinoma (PDEC). The
“carcinoid” occurs only rarely in the testis, but is fairly
common in the ovary. The majority of primary ovarian
“carcinoid” tumors coexist with teratomas [17], but testi-
cular “carcinoid” tumors are not always associated with
teratomas [1, 13, 16, 20, 26]. Two possible explanations
have been proposed for the origins of testicular “carcinoid
tumors” [20]: (1) carcinoid tumors originate from the NE
cells present in the intestinal or bronchial component of
teratomas that consist of various types mature and immature
Fig. 3. Localization of CGA and PALP in the same E-T cells. In double immunohistochemical staining for CGA (brown) and PLAP (blue) (A),
CGA and PALP are observed in the same cell. Analysis by CLSM demonstrates the detected cells are positively labeled by both CGA (yellow)
(B) and PLAP (cyanogen) (C), and the merged image shows both signals in the same cell (D). Bars=50 µm (A), 5 µm (B–D).Neuroendocrine Characteristic in Testicular GCTs 149
Fig. 4. Expression of CD30, a marker of embryonal carcinoma, in neuroendocrine carcinoma. CLSM shows that neuroendocrine carcinoma
demonstrates expression of CD30 (A, D), CGA (B) and synaptophysin (C). Intracytoplasmic localization of CD30 in embryonal carcinoma is in
the cytoplasm (D), in contrast to typical expression pattern at cellular membrane in embryonal carcinoma (E). Bars=20 µm (A–C), 2.0 µm (D, E).
Fig. 5. A proposed hypothesis for histogenesis of neuroendocrine tumor in testis. The two cases presented in this study may indicate alterative
pathways from embryonal carcinoma other than through mature teratoma (Red circled tumor; CGA positive tumor in this study).Kumaki et al. 150
tissue; and (2) carcinoid tumors originate from NE cells
present in the non-neoplastic gonadal elements. Although
there is no evidence of NE cells in the gonad, pluripotent
cells similar to ES cells were recently found in mouse testis
[8].
Primordial germ cells appear in the yolk sac endoderm
and migrate to the gonadal ridge in early embryonic life [21,
24]. Because germ cell tumors are thought to be derived
from these primordial germ cells before they become gam-
etes, various mature or immature histological features are
observed which mimic the process of normal development.
At present, embryonal carcinoma is suggested to occur from
seminoma because seminoma cells are thought to have pluri-
potency, and nonseminomatous germ cell tumors (NSGCTs)
are assumed to occur from embryonal carcinoma or semi-
noma [3, 9, 19].
The third tumor element, NEC, in our study was inter-
preted as PDEC and was found to co-exist with seminoma;
these two tumors were located next to each other and were
admixed at the transition. This tumor was not only positive
for NE markers, but also for one of the markers for embryo-
nal carcinoma, CD30, even though PLAP was negative. The
results of immunohistochemical staining and co-existence of
NEC and seminoma showed that this third tumor element
has a potential for differentiation into both embryonal carci-
noma and NETs (Fig. 5). Moreover, the fact that less mature
germ cell tumors than teratoma have an NE characteristic
may support the hypothesis that NEC could be derived from
GCTs.
One of the major pluripotent cells is the embryonal
stem (ES) cell in human and other species. ES cells cultured
under special conditions or with various materials can differ-
entiate into myocardial cells, hepatic cells, hematopoietic
cells and even into endocrine cells. Differentiated endocrine
cells are similar to beta cells of pancreatic islet cells, and can
secrete insulin in vitro [18]. However, morphological studies
of ES cells have been not extensive. Kanatsu-Shinohara et
al. report that testicular cells of newborn mouse can continue
to proliferate under the same conditions of ES cell culture
method [7]. These cultured cells reveal very similar charac-
ters to ES cells, and their germline potential is preserved.
These findings suggest that multipotent stem cells are
present in the testis and could differentiate into neuroendo-
crine cells in the gonad. Our findings support the spontane-
ous differentiation of NE cells from ES cells in the culture
condition.
In conclusion, NE differentiation was observed in three
categories: (1) “E&T tumor”, (2) “E-T cell”, and (3) NEC.
Our findings suggest that germ cell tumor acquires the NE
characteristic during the immature phase of teratomatous
differentiation (“E-T cell”). NEC in our case was of particu-
lar interest because of the presence of NEC and seminoma
in the same tumor, both of which were decorated by CD30
suggesting that NE differentiate from less differentiated
seminoma.
These findings may shed new light on cancer patho-
biology by clarifying the pathway of NE differentiation in
various cancers including GCTs. Moreover, it should be
emphasized that we can more precisely observe the tumor
cell structure by use of CLSM with bright immunohisto-
chemical localization of dyes in the same cell, DAB and Fast
Blue BB, and that CLSM is particularly useful to apply to
specimens of resected archival human tumors.
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